International Max Planck Research Schools for Molecular Organ Biology (IMPRS-MOB)
The
International Max Planck Research Schools (IMPRS) have become an essential part in the translational education of Ph.D. students. Talented junior scientists are offered the opportunity to earn a doctorate under excellent research conditions.
Further general information on the IMPRS can be found on: http://www.mpg.de/en/imprs
Our graduate school was founded in 2008 as IMPRS for Heart and Lung Research. After 12 successful years, continued innovation within our faculty and curriculum drove us to change the name of the school in 2020 to "IMPRS for Molecular Organ Biology".
IMPRS-MOB has established excellent training opportunities for young scientists who will need to integrate molecular, cellular, organ and whole organism levels of complex biological systems to tackle the most important future scientific challenges. Scientific experts from all over the world work together in an rich scientific environment supported by state-of-the-art service facilities in the field of imaging, proteomics, bioinformatics, next generation sequencing and generation of transgenic animals (mouse and zebra fish).
Max Planck Institute for Heart and Lung Research
Scientists at the
Max Planck Institute for Heart and Lung Research (MPI-HLR) study the structure and workings of the heart, blood vessels and lungs. Among other things, their findings are intended to contribute to a better understanding of diseases in these organs and in developing possible treatments. The scientists, for example, examine how cells in the heart, blood vessel or lung tissue communicate with each other, and which signal molecules influence their function. They also study how function can be restored to damaged tissue. Stem cells – in other words precursor cells that can grow into specialised heart, blood vessel or lung cells – are therefore another important field of research for the Institute.
Directors at the Max Planck Institute for Heart and Lung Research and their Research Focus:
- Didier Stainier: Developmental Genetics
- Stefan Offermanns: Pharmacology
- Thomas Braun: Cardiac Development and Remodelling
Further information on the MPI-HLR can be found on: http://www.mpi-hlr.de
Max Planck Society
The Max Planck Society is Germany's most successful research organization. Since its establishment in 1948, no fewer than 22 Nobel laureates have emerged from the ranks of its scientists, putting it on a par with the best and most prestigious research institutions worldwide. The more than 15,000 publications each year in internationally renowned scientific journals are proof of the outstanding research work conducted at Max Planck Institutes – and many of those articles are among the most-cited publications in the relevant field.
Max Planck Institutes are built up solely around the world's leading researchers. They themselves define their research subjects and are given the best working conditions, as well as free reign in selecting their staff.
Currently 86 Max Planck Institutes conduct basic research in the service of the general public in the natural sciences, life sciences, social sciences, and the humanities. Max Planck Institutes focus on research fields that are particularly innovative, or that are especially demanding in terms of funding or time requirements.
Further information about the Max Planck Society can be found on: http://www.mpg.de/en